Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

Share Price is delayed by 15 minutes
Get Live Data
7.50    -0.40 (-5.06%)
Bid:
7.00
Ask:
8.00
Spread: 1.00 (14.286%)
Market Cap: £474.94m
AGY Live PriceLast checked at - London Stock Exchange

Intraday Allergy Thera. Share Chart

Allergy Thera. News

Allergy Therapeutics revenue drops but optimistic about funding
20 Jan 2023

Allergy Therapeutics revenue drops but optimistic about funding

(Alliance News) - Allergy Therapeutics PLC on Friday said it expects a drop in revenue during the first half of its financial year, but it remains con...

LONDON MARKET CLOSE: FTSE 100 edges higher and New York stocks jump
29 Dec 2022

LONDON MARKET CLOSE: FTSE 100 edges higher and New York stocks jump

(Alliance News) - London's FTSE 100 achieved a solid, though unspectacular, gain during the final full trading of the year on Thursday, with investors...

LONDON MARKET MIDDAY: Covid concerns in China drag stocks lower
29 Dec 2022

LONDON MARKET MIDDAY: Covid concerns in China drag stocks lower

(Alliance News) - Stock prices in London at midday continued to be weighed down by the worrying surge in Covid-19 cases as China swiftly re-opens from...

AIM WINNERS & LOSERS: Allergy Therapeutics plunges as results delayed
29 Dec 2022

AIM WINNERS & LOSERS: Allergy Therapeutics plunges as results delayed

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

LONDON MARKET OPEN: Sea of red as investors fret over Covid in China
29 Dec 2022

LONDON MARKET OPEN: Sea of red as investors fret over Covid in China

(Alliance News) - Stock prices in London opened lower on Thursday amid risk-off sentiment across Europe, as concerns grew about rising Covid cases in...

Allergy Therapeutics shares halve as delayed audit to mean suspension
29 Dec 2022

Allergy Therapeutics shares halve as delayed audit to mean suspension

Alliance News) - Allergy Therapeutics PLC on Thursday said it shares will be suspended next week, due to delays in completing the audit of its annual ...

AIM WINNERS & LOSERS: Redcentric boasts "transformational" half-year
8 Dec 2022

AIM WINNERS & LOSERS: Redcentric boasts "transformational" half-year

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Allergy Therapeutics proffers peanut progress despite cost concerns
8 Dec 2022

Allergy Therapeutics proffers peanut progress despite cost concerns

(Alliance News) - Allergy Therapeutics PLC on Thursday saw shares drop despite the start of its peanut allergy testing trial, after it confirmed that ...